I said yes to an Alzheimer’s blood test. Then I panicked.
New blood-based diagnostic platforms for Alzheimer’s disease have triggered a shift in medical testing and patient apprehension.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Circular Genomics has launched its CircPATH platform, a tool designed for the early detection of Alzheimer’s disease. Simultaneously, Medical News Today and Medical Xpress are reporting on the emergence of the SECmere blood test and findings regarding blood proteins that may indicate dementia risk.
Coverage from The Washington Post highlights the psychological response to receiving results from such tests. Future reports will likely address the clinical adoption of these testing platforms.
It remains to be determined how the medical community will manage the diagnostic process alongside the emotional impact on patients receiving early detection results.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (71% supported) Updated 137d ago.
Quick answers
What is the CircPATH platform?
It is a new diagnostic platform from Circular Genomics designed for the early detection of Alzheimer’s disease.
What do the new blood tests detect?
Coverage indicates these tests utilize circular RNAs and specific blood proteins to identify Alzheimer's-related changes.
How early can these tests identify risk?
According to Medical Xpress, certain blood proteins can flag dementia risk decades before symptoms appear.
Coverage (9)
- New Alzheimer’s blood test may tell when symptoms are around the corner Florida Hospital News and Healthcare Report · 137d ago
- Can a blood test predict dementia? 4 latest studies show promise Medical News Today · 137d ago
- What Blood Tests Could Mean for Early Alzheimer’s Detection Being Patient · 137d ago
- Lighting up the way to faster, cheaper diagnosis of Alzheimer's disease Alzheimer's Society · 137d ago
- Circular Genomics Unveils Its CircPATH™ Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of Alzheimer's Disease Newswise · 138d ago
- New ‘SECmere’ blood test could spot Alzheimer’s-related changes sooner Medical News Today · 138d ago
- A blood protein can flag dementia risk decades before symptoms appear Medical Xpress · 138d ago
- Blood-based circular RNAs for early diagnosis of Alzheimer’s disease Nature · 138d ago
- I said yes to an Alzheimer’s blood test. Then I panicked. The Washington Post · 138d ago
Topics
Related trends
Trying Tourette's device was the best day of my life
Clinical trials show a new £500 wrist-worn nerve-stimulation device cuts Tourette's tics by over 25 percent.
MIT scientists discover a surprising way to boost the brain’s nighttime cleaning system
MIT researchers find timed pink noise can amplify the brain's nightly waste-clearance waves that fade with age.
David Cameron on Living With Brexit and Ending Alzheimer’s
Former UK Prime Minister David Cameron reveals his mother begged to die from dementia while urging billions in NHS Alzheimer's funding and 18-week diagnosis targets.
Neurologists Say This Is 1 Of The Best Ways To Protect Your Brain As You Age
Neurologists and health sources outline major risk factors, misconceptions, and everyday habits concerning dementia and Alzheimer's disease.
Alzheimer's warning signs could emerge years before memory loss, study finds
A study finds hearing problems can appear up to 10 years before memory loss in people who later develop early-onset Alzheimer's disease.
This Common Daytime Habit May Be Linked To A Higher Dementia Risk, Study Finds
A study of nearly 1,000 adults aged 65 and older linked frequent, unintentional daytime napping with a higher risk of dementia, researchers say.